We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$499M
AUM Growth
+$4.35M
Cap. Flow
-$7.39M
Cap. Flow %
-1.48%
Top 10 Hldgs %
24.94%
Holding
248
New
15
Increased
55
Reduced
102
Closed
20

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.33M
2
MMM icon
3M
MMM
+$4.77M
3
LULU icon
lululemon athletica
LULU
+$4.74M
4
EL icon
Estee Lauder
EL
+$4.6M
5
BLK icon
Blackrock
BLK
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 19.5%
2 Technology 18.93%
3 Financials 12.55%
4 Consumer Discretionary 10.74%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
101
Insmed
INSM
$21.3B
$1.14M 0.23%
59,729
-14,000
-19% -$266K
SRCI
102
DELISTED
SRC Energy Inc
SRCI
$1.09M 0.22%
101,900
+28,500
+39% +$273K
DBD
103
DELISTED
Diebold Nixdorf Incorporated
DBD
$1.09M 0.22%
27,396
-3,510
-11% -$126K
OMCL icon
104
Omnicell
OMCL
$1.71B
$1.09M 0.22%
38,000
-900
-2% -$24.6K
WM icon
105
Waste Management
WM
$90.5B
$1.08M 0.22%
25,805
+230
+0.9% +$9.64K
IBM icon
106
IBM
IBM
$213B
$1.08M 0.22%
5,890
-52
-0.9% -$9.15K
DD
107
DELISTED
Du Pont De Nemours E I
DD
$1.05M 0.21%
16,497
SPSC icon
108
SPS Commerce
SPSC
$2.72B
$1.04M 0.21%
33,800
+1,100
+3% +$36K
CAVM
109
DELISTED
Cavium, Inc.
CAVM
$1.02M 0.2%
23,400
-500
-2% -$19.6K
IONS icon
110
Ionis Pharmaceuticals
IONS
$9.06B
$1.02M 0.2%
23,612
DRI icon
111
Darden Restaurants
DRI
$23.6B
$1.02M 0.2%
22,426
-3,603
-14% -$161K
JAZZ icon
112
Jazz Pharmaceuticals
JAZZ
$15.8B
$992K 0.2%
7,150
-42,405
-86% -$6.38M
BCRX icon
113
BioCryst Pharmaceuticals
BCRX
$2.24B
$984K 0.2%
93,000
-46,000
-33% -$490K
AYI icon
114
Acuity Brands
AYI
$10B
$981K 0.2%
7,400
-50
-0.7% -$6.61K
CA
115
DELISTED
CA, Inc.
CA
$978K 0.2%
31,554
-1,960
-6% -$63.9K
WPRT
116
Westport Fuel Systems
WPRT
$33.4M
$971K 0.19%
6,703
+905
+16% +$156K
GHM icon
117
Graham Corp
GHM
$1.16B
$967K 0.19%
30,375
-750
-2% -$26.3K
SUPX
118
DELISTED
SUPERTEX INC
SUPX
$961K 0.19%
29,150
-650
-2% -$19.5K
KEG
119
DELISTED
KEY ENERGY SERVICES INC
KEG
$945K 0.19%
102,300
+15,700
+18% +$145K
NGS icon
120
Natural Gas Services Group
NGS
$468M
$937K 0.19%
31,100
-300
-1% -$8.94K
MOVE
121
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
$927K 0.19%
80,150
+21,400
+36% +$289K
ELLI
122
DELISTED
Ellie Mae Inc
ELLI
$921K 0.18%
31,950
-4,900
-13% -$137K
EVR icon
123
Evercore
EVR
$12.3B
$906K 0.18%
16,400
-350
-2% -$20K
COP icon
124
ConocoPhillips
COP
$145B
$900K 0.18%
12,794
-3,400
-21% -$228K
MOV icon
125
Movado Group
MOV
$866M
$898K 0.18%
19,725
+6,825
+53% +$278K

Similar funds

Franklin Street Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Franklin Street Advisors held 248 positions worth $499M, up 0.88% from $495M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Franklin Street Advisors's Q1 2014 filing shows 15 new, 55 increased, 102 reduced and 20 closed positions. Its largest new stake was Teva Pharmaceuticals: 115,247 shares worth $6.09M. The largest sale was Jazz Pharmaceuticals, an estimated $6.38M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • Franklin Street Advisors's largest Q1 2014 buy was Teva Pharmaceuticals: 115,247 shares worth $6.09M.
  • Franklin Street Advisors added most to 3M in Q1 2014, an estimated $4.77M increase.
  • Franklin Street Advisors's biggest Q1 2014 reduction was Jazz Pharmaceuticals, cutting an estimated $6.38M.
  • Franklin Street Advisors fully exited CAMERON INTERNATIONAL CORPORATION in Q1 2014, selling an estimated $4.68M.
  • Franklin Street Advisors's ten largest holdings make up 25% of its $499M portfolio in Q1 2014.
  • Franklin Street Advisors opened 15 new positions and closed 20 in Q1 2014.
  • Franklin Street Advisors's portfolio value rose 0.88% quarter-over-quarter to $499M.

Based on Franklin Street Advisors's 13F filing for Q1 2014, filed 4 Apr 2014.